NSE filing, NSE: SAKAR. Summary written from the filing by ALFA Finder's alert engine.
Sakar Healthcare Ltd: key numbers
- Share price
- ₹944.80
- Market cap
- ₹2,102 Cr
- Revenue (annual)
- ₹251.7 Cr
- Net profit (annual)
- ₹30.48 Cr
- P/E (TTM)
- 49.0×Sector 45.9×
- Promoter holding
- 51.70%-0.82% QoQ
- FII holding
- 12.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sakar Healthcare Ltd
All →Sakar Healthcare Earnings Call Transcript: Key Takeaways
Sakar Healthcare delivered exceptional growth as its oncology segment scales, with EBITDA doubling and margins expanding significantly due to product-mix shifts. Management is pivoting from a non-oncology focus to high-margin oncology formulations and APIs.
- Call
- Guides 35% growth
Sakar Healthcare Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue Rs87.4 Cr (+52% YoY), EBITDA Rs24.4 Cr (28% margin), PAT Rs11.3 Cr (+149%); pitch centres on oncology integration.
Sakar Healthcare Results Update
Sakar Healthcare reported Q2 FY27 revenue of ₹87.42 Cr and PAT of ₹11.31 Cr, up 149% YoY. EBITDA rose 114% to ₹24.35 Cr on strong oncology approvals and commercial supply commencement.
Sakar Healthcare Q2 FY27 Results: Net Profit ₹11.3 Cr, Up 151.1% YoY
Sakar Healthcare Ltd reported revenue from operations of ₹87.4 Cr (+51.7% YoY) and net profit of ₹11.3 Cr (+151.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹11.3 Cr · +151.1% YoY
Sakar Healthcare Board Meeting Date
Sakar Healthcare has scheduled a board meeting for October 23, 2026, to approve its unaudited quarterly financial results for the period ended September 2026.
Sakar Healthcare Business Update
Sakar Healthcare says its oncology export model is expanding, with 22 Marketing Authorizations granted and commercial supply starting from its EU GMP site. No monetary value stated.
Other financial results announcements
All →Mac Charles (India) Q2 FY27 Results: Net Loss of ₹19.4 Cr, Loss Widens
Mac Charles (India) Ltd reported revenue from operations of ₹33 Cr (+39.2% YoY) and a net loss of ₹19.4 Cr for Q2 FY27.
- Key figure
- Net loss ₹19.4 Cr
PSP Projects Q2 FY27 Results: Net Profit ₹30.2 Cr, Up 86.4% YoY
PSP Projects Ltd reported revenue from operations of ₹1,113 Cr (+58.4% YoY) and net profit of ₹30.2 Cr (+86.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹30.2 Cr · +86.4% YoY
Axtel Industries Q2 FY27 Results: Net Profit ₹3.7 Cr, Down 63.4% YoY
Axtel Industries Ltd reported revenue from operations of ₹44.6 Cr (-33.7% YoY) and net profit of ₹3.7 Cr (-63.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹3.7 Cr · -63.4% YoY
Regal Entertainment & Consultants Q2 FY27 Results: Net Loss of ₹0.1 Cr
Regal Entertainment & Consultants Ltd reported revenue from operations of ₹0.2 Cr (-33.3% YoY) and a net loss of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.1 Cr
Teamo Productions HQ Q2 FY27 Results: Net Loss of ₹1.8 Cr
Teamo Productions HQ Ltd reported revenue from operations of ₹24.8 Cr (-51.4% YoY) and a net loss of ₹1.8 Cr for Q2 FY27.
- Key figure
- Net loss ₹1.8 Cr
UPL Q2 FY27 Results: Net Profit ₹452 Cr, Down 26.1% YoY
UPL Ltd reported revenue from operations of ₹11,860 Cr (-1.3% YoY) and net profit of ₹452 Cr (-26.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹452 Cr · -26.1% YoY